Any sales and use of a rival mark by the Defendant after receipt of Notice is at the peril of the Defendant.
  •  Emcure Pharmaceuticals Ltd. vs. Corona Remedies Pvt. Ltd. High Court of Bombay, 10.09.2014
  • Cadila Pharmaceuticals Ltd. vs. Sami Khatib; 2011 (3) Bom CR 587
  • Glaxo Orthopaedic U.K. Ltd. vs. Samrat Pharma; AIR 1984 Delhi 265